158 related articles for article (PubMed ID: 17266900)
1. [Use of complementary and alternative medicine and drug abuse in patients with inflammatory bowel disease].
García-Planella E; Marín L; Domènech E; Bernal I; Mañosa M; Zabana Y; Gassull MA
Med Clin (Barc); 2007 Jan; 128(2):45-8. PubMed ID: 17266900
[TBL] [Abstract][Full Text] [Related]
2. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.
Lakatos PL; Czegledi Z; David G; Kispal Z; Kiss LS; Palatka K; Kristof T; Nagy F; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovacs A; Racz I; Lakatos L
J Crohns Colitis; 2010 Sep; 4(3):283-90. PubMed ID: 21122517
[TBL] [Abstract][Full Text] [Related]
3. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].
Lakatos L; Czeglédi Z; Dávid G; Kispál Z; Kiss LS; Palatka K; Kristóf T; Molnár T; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovács A; Rácz I; Lakatos PL
Orv Hetil; 2010 Feb; 151(7):250-8. PubMed ID: 20133244
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea.
Park DI; Cha JM; Kim HS; Park HJ; Shin JE; Hong SN; Hong SS; Kim WJ
Complement Ther Med; 2014 Feb; 22(1):87-93. PubMed ID: 24559822
[TBL] [Abstract][Full Text] [Related]
5. Complementary alternative medicine in patients with inflammatory bowel disease: use and attitudes.
Quattropani C; Ausfeld B; Straumann A; Heer P; Seibold F
Scand J Gastroenterol; 2003 Mar; 38(3):277-82. PubMed ID: 12737442
[TBL] [Abstract][Full Text] [Related]
6. Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study.
Bertomoro P; Renna S; Cottone M; Riegler G; Bossa F; Giglio L; Pastorelli L; Papi C; Castiglione F; Angelucci E; Pica R; Di Paolo MC; D'Incà R
J Crohns Colitis; 2010 Sep; 4(3):291-300. PubMed ID: 21122518
[TBL] [Abstract][Full Text] [Related]
7. Complementary and alternative medicine in patients with inflammatory bowel disease: A survey performed in a tertiary center in Chile.
Fernández A; Simian D; Quera R; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Fluxá D
Complement Ther Med; 2018 Oct; 40():77-82. PubMed ID: 30219473
[TBL] [Abstract][Full Text] [Related]
8. Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal survey.
Bensoussan M; Jovenin N; Garcia B; Vandromme L; Jolly D; Bouché O; Thiéfin G; Cadiot G
Gastroenterol Clin Biol; 2006 Jan; 30(1):14-23. PubMed ID: 16514377
[TBL] [Abstract][Full Text] [Related]
9. Cannabis Use in Persons With Inflammatory Bowel Disease and Vulnerability to Substance Misuse.
Hansen TM; Sabourin BC; Oketola B; Bernstein CN; Singh H; Targownik LE
Inflamm Bowel Dis; 2020 Aug; 26(9):1401-1406. PubMed ID: 31725152
[TBL] [Abstract][Full Text] [Related]
10. Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Diseases: A Single-Center Survey.
Serpico MR; Boyle BM; Kemper KJ; Kim SC
J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):651-657. PubMed ID: 26960176
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.
Weizman AV; Ahn E; Thanabalan R; Leung W; Croitoru K; Silverberg MS; Steinhart AH; Nguyen GC
Aliment Pharmacol Ther; 2012 Feb; 35(3):342-9. PubMed ID: 22176478
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease.
Gröchenig HP; Waldhör T; Haas T; Wenzl H; Steiner P; Koch R; Feichtenschlager T; Eckhardt G; Mayer A; Kirchgatterer A; Ludwiczek O; Platzer R; Papay P; Gartner J; Fuchssteiner H; Miehsler W; Peters PG; Reicht G; Kutschera M; Dejaco C; Vogelsang H; Novacek G;
Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1211-1219. PubMed ID: 31498280
[TBL] [Abstract][Full Text] [Related]
13. COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN BRAZILIAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
Henriques DP; Oliveira RR; Vanni J; Lima HP; Otiti JV; Neves FRM; Hammerle MB; Sassaki LY; Zaltman C
Arq Gastroenterol; 2022; 59(3):375-382. PubMed ID: 36102435
[TBL] [Abstract][Full Text] [Related]
14. Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study.
Koning M; Ailabouni R; Gearry RB; Frampton CM; Barclay ML
Inflamm Bowel Dis; 2013; 19(4):767-78. PubMed ID: 23429459
[TBL] [Abstract][Full Text] [Related]
15. The who-when-why triangle of CAM use among Portuguese IBD patients.
Portela F; Dias CC; Caldeira P; Cravo M; Deus J; Gonçalves R; Lago P; Morna H; Peixe P; Ramos J; Sousa H; Tavares L; Vasconcelos H; Magro F; Ministro P
Dig Liver Dis; 2017 Apr; 49(4):388-396. PubMed ID: 28117198
[TBL] [Abstract][Full Text] [Related]
16. Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).
Opheim R; Hoivik ML; Solberg IC; Moum B;
J Crohns Colitis; 2012 Apr; 6(3):345-53. PubMed ID: 22405172
[TBL] [Abstract][Full Text] [Related]
17. Health-related self-perceptions over time and provider-based Complementary and Alternative Medicine (CAM) use in people with inflammatory bowel disease or arthritis.
Sirois FM
Complement Ther Med; 2014 Aug; 22(4):701-9. PubMed ID: 25146075
[TBL] [Abstract][Full Text] [Related]
18. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey.
Langhorst J; Anthonisen IB; Steder-Neukamm U; Lüdtke R; Spahn G; Michalsen A; Dobos GJ
Inflamm Bowel Dis; 2005 Mar; 11(3):287-95. PubMed ID: 15735435
[TBL] [Abstract][Full Text] [Related]
19. Complementary and alternative medicine (CAM) practices and dietary patterns in children with inflammatory bowel disease in Singapore and Malaysia.
Ong F; Seah Lee W; Lin C; Ng RT; Yee Wong S; Lim SL; Quak SH; Aw M
Pediatr Neonatol; 2018 Oct; 59(5):494-500. PubMed ID: 29352665
[TBL] [Abstract][Full Text] [Related]
20. Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis.
Weiss A; Friedenberg F
Drug Alcohol Depend; 2015 Nov; 156():84-89. PubMed ID: 26422462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
